Print Page     Close Window     

SEC Filings

6-K
AC IMMUNE SA filed this Form 6-K on 06/28/2017
Entire Document
 
 
D.The total maximum amount of variable compensation for the members of the Executive Committee for the current year 2017, i.e., CHF 782,000 (cash compensation plus social security costs); and

 

E.The maximum grant of equity or equity linked instruments for the members of the Executive Committee from 1 July 2017 to 30 June 2018 with maximum value of CHF 3,472,000 (equity or equity linked instruments value plus social security costs).

 

Agenda Item 5: Election of the Members of the Board

 

AC Immune shareholders approved the re-election of Martin Velasco as member and as Chairman of the Board, Peter Bollmann, Friedrich von Bohlen, Andrea Pfeifer, Detlev Riesner and Thomas Graney as members of the Board of Directors, each until the end of the next Ordinary General Meeting.

 

Agenda Item 6: Election to the Compensation, Nomination & Corporate Governance Committee

 

AC Immune shareholders approved the re-election of Detlev Riesner, Martin Velasco and Tom Graney as members of the Compensation, Nomination & Corporate Governance Committee, each until the end of the next Ordinary General Meeting.

 

Agenda Item 7: Re-Election of the independent proxy

 

AC Immune shareholders approved the re-election of Bugnion Ballansat Ehrler, represented by Gérald Virieux, as AC Immune’s independent proxy until the end of the next Ordinary General Meeting.

 

Agenda Item 8: Re-Election of the Auditors

 

AC Immune shareholders approved the re-election of Ernst & Young SA, in Lancy, for a term of office of one year.

 

 

© AC Immune 2015